Tony Eglezos
Corporate Officer/Principal at STARPHARMA HOLDINGS LIMITED
Net worth: 21 818 $ as of 2024-03-30
Profile
Tony Eglezos is currently the Vice President of Business Development at Starpharma Holdings Ltd.
Prior to this, he worked as the Senior Director of Business Development and Licensing at CSL Ltd.
from 2006 to 2013.
He also held a position as Director of Commercial Operations and Pharmaceuticals at Seqirus Pty Ltd.
Dr. Eglezos holds a doctorate from the University of Melbourne and an MBA from the University of Technology Sydney.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-29 | 267,542 ( 0.06% ) | 21 818 $ | 2024-03-30 |
Tony Eglezos active positions
| Companies | Position | Start |
|---|---|---|
| STARPHARMA HOLDINGS LIMITED | Corporate Officer/Principal | 2013-08-11 |
Former positions of Tony Eglezos
| Companies | Position | End |
|---|---|---|
| CSL LIMITED | Corporate Officer/Principal | 2013-07-31 |
Seqirus Pty Ltd.
 Seqirus Pty Ltd. BiotechnologyHealth Technology Part of CSL Ltd., Seqirus Pty Ltd. is an Australian company that develops and manufactures vaccines and plasma protein biotherapies. The private company is based in Parkville, Australia. | Corporate Officer/Principal | - |
Training of Tony Eglezos
| University of Melbourne | Doctorate Degree |
| University of Technology Sydney | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CSL LIMITED | Health Technology |
| STARPHARMA HOLDINGS LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Seqirus Pty Ltd.
Seqirus Pty Ltd. BiotechnologyHealth Technology Part of CSL Ltd., Seqirus Pty Ltd. is an Australian company that develops and manufactures vaccines and plasma protein biotherapies. The private company is based in Parkville, Australia. | Health Technology |
- Stock Market
- Insiders
- Tony Eglezos
